CABG MEDICAL ANNOUNCLLOTMENT OPTIONES EXERCISE OF OVER-A

CABG Medical announced that the underwriters of the company's recent initial public offering of its common stock have exercised in full their over-allotment option to purchase an additional 825,000 shares of the company's common stock at a price of $5.50 per share, before deducting underwriting discounts and commissions.

PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=204679&categoryid=36%2C61)